Randomised Controlled Trial: Intrauterine Misoprostol Versus Sublingual Misoprostol In The Prevention Of Postpartum Hemorrhage At Elective Caesarean Section At Korle Bu Teaching Hospital, Ghana.
Phase 2
Recruiting
- Conditions
- Postpartum haemorrhage
- Registration Number
- PACTR202309644870215
- Lead Sponsor
- Self sponsored DR CHIDINMA PEACE OHACHE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 148
Inclusion Criteria
Pregnant women 18 years and above
Singleton gestation
Gestational age between 37 weeks 0 days to 41 weeks 3 days.
Exclusion Criteria
haemoglobin level <8g/dl
antepartum haemorrhage (Placenta Previa, Abruptio placentae)
multifetal pregnancy
previous history of PPH
polyhydramnios (AFI >25cm or DVP >8cm)
large uterine fibroid (at least one nodule with size >10cm) and/or any FIGO Type 0 fibroids
post-placental IUCD insertion
known coagulation disorders
known allergy to Misoprostol.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method